Produção e caracterização de implantes nanotexturizados de titânio associado a liberação gradual de fármacos

• Autor(a) principal: Veleda, Paula Prá
• Data de Publicação: 2012
• Tipo de documento: Tese
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da PUC_RS
• Texto Completo: http://tede2.pucrs.br/tede2/handle/tede/3219
• topic: ENGENHARIA DE MATERIAIS; OSSEOINTEGRAÇÃO (ODONTOLOGIA); TITÂNIO; IMPLANTES DENTÁRIOS OSSEOINTEGRADOS; HORMÔNIO DO CRESCIMENTO; MICROSCOPIA ÓPTICA; CNPQ::ENGENHARIAS

The aim of this study was to assess, in vivo, the effect of two different surface treatments of titanium implants - plasma-spray (PSA) and nano-textured plasma-spray (PSA-nano) - at the bone-to-implant interface (osseointegration), associated or not to the recombinant human growth hormone (rhGH). Twenty-four prototypes of pure titanium implants, 6-mm long and 2-mm wide, were especially fabricated in a cylindrical shape and placed in 12 New Zealand rabbit s tibiae. The implants were divided into four groups: 1) PSA implants without rhGH, 2) PSA implants with rhGH, 3) PSA-nano implants without rhGH and, lastly, 4) PSA-nano implants with rhGH. The animals were sacrificed 14 and 42 after the surgeries. Samples were collected and analysed by optical microscopy (OM), scanning electronic microscopy (SEM) and infrared microscopy (μ-FTIR), besides the pull-out mechanical test. The results showed that in the early stage of osseointegration, the recombinant human growth hormone has favored new bone formation, regardless the surface treatment. Howev-er, in the later stage, the nano-textured surface, even without the hormone, has made a positive influence on the new bone formation, when compared to its use with hormone. In this stage, only the plasma-spray surface (PSA) has been favored by the growth hormone